Loading…

Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States

Local excision (LE) for early-stage gastric cancer has expanded in the United States over recent years, however, national outcomes are unknown. The objective of the study was to evaluate national survival outcomes following LE for early-stage gastric cancer. Patients with resectable gastric adenocar...

Full description

Saved in:
Bibliographic Details
Published in:Surgical oncology 2023-06, Vol.48, p.101937-101937, Article 101937
Main Authors: Newland, John J., Johnson, Abree M., Feng, Zhaoyong, Kim, Raymond E., Williams, Richelle T., Hanna, Nader N., Mullins, C. Daniel, Hu, Yinin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c311t-69afc9582ba10ea1dd0b368c7888e799284f6c1500b6a5487e646f8f7e6c16a63
container_end_page 101937
container_issue
container_start_page 101937
container_title Surgical oncology
container_volume 48
creator Newland, John J.
Johnson, Abree M.
Feng, Zhaoyong
Kim, Raymond E.
Williams, Richelle T.
Hanna, Nader N.
Mullins, C. Daniel
Hu, Yinin
description Local excision (LE) for early-stage gastric cancer has expanded in the United States over recent years, however, national outcomes are unknown. The objective of the study was to evaluate national survival outcomes following LE for early-stage gastric cancer. Patients with resectable gastric adenocarcinoma between 2010 and 2016 were identified from the National Cancer Database then classified by LE curability into eCuraA (high) and eCuraC (low) according to Japanese Gastric Cancer Association guidelines. Demographics, clinical/provider descriptors, and perioperative/survival outcomes were extracted. Propensity-weighted cox proportional hazards regression assessed factors associated with overall survival. Patients were stratified into eCuraA (N = 1167) and eCuraC (N = 13,905) subgroups. Postoperative 30-day mortality (0% vs 2.8%, p 
doi_str_mv 10.1016/j.suronc.2023.101937
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2801980952</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960740423000373</els_id><sourcerecordid>2801980952</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-69afc9582ba10ea1dd0b368c7888e799284f6c1500b6a5487e646f8f7e6c16a63</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EotvCP0DIRy5Zxk7ijwsSqvioVKkH6NnyTibFq8RebAfRf09WKRw5jTR63nk1D2NvBOwFCPX-uC9LThH3EmR7XtlWP2M7YbRt2lbCc7YDq6DRHXQX7LKUIwAoLcVLdtFq6I3VcsfwbqmYZircj5UypzikgukUkE8J_cTpN4YSUuRp5OTz9NiU6h-IP_hS80r5geIKZgwxzZ6HyOsP4vcxVBr4t-orlVfsxeinQq-f5hW7__zp-_XX5vbuy831x9sGWyFqo6wf0fZGHrwA8mIY4NAqg9oYQ9paabpRoegBDsr3ndGkOjWacZ0olFftFXu33T3l9HOhUt0cCtI0-UhpKU6aVZIB28sV7TYUcyol0-hOOcw-PzoB7qzXHd2m1531uk3vGnv71LAcZhr-hf76XIEPG0Drn78CZVcwUEQaQiasbkjh_w1_AKxljmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2801980952</pqid></control><display><type>article</type><title>Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States</title><source>ScienceDirect Freedom Collection</source><creator>Newland, John J. ; Johnson, Abree M. ; Feng, Zhaoyong ; Kim, Raymond E. ; Williams, Richelle T. ; Hanna, Nader N. ; Mullins, C. Daniel ; Hu, Yinin</creator><creatorcontrib>Newland, John J. ; Johnson, Abree M. ; Feng, Zhaoyong ; Kim, Raymond E. ; Williams, Richelle T. ; Hanna, Nader N. ; Mullins, C. Daniel ; Hu, Yinin</creatorcontrib><description>Local excision (LE) for early-stage gastric cancer has expanded in the United States over recent years, however, national outcomes are unknown. The objective of the study was to evaluate national survival outcomes following LE for early-stage gastric cancer. Patients with resectable gastric adenocarcinoma between 2010 and 2016 were identified from the National Cancer Database then classified by LE curability into eCuraA (high) and eCuraC (low) according to Japanese Gastric Cancer Association guidelines. Demographics, clinical/provider descriptors, and perioperative/survival outcomes were extracted. Propensity-weighted cox proportional hazards regression assessed factors associated with overall survival. Patients were stratified into eCuraA (N = 1167) and eCuraC (N = 13,905) subgroups. Postoperative 30-day mortality (0% vs 2.8%, p &lt; 0.001) and readmission (2.3% vs 7.8%, p = 0.005) favored LE. Local excision was not associated with survival on propensity-weighted analyses. However, among eCuraC patients, LE was associated with higher likelihood of positive margins (27.1% vs 7.0%, p &lt; 0.001), which was the strongest predictor of poor survival (HR 2.0, p &lt; 0.001). Although early morbidity is low, oncologic outcomes following LE are compromised for eCuraC patients. These findings support careful patient selection and treatment centralization in the early adoption phase of LE for gastric cancer. •Local excision has lower morbidity and mortality than radical resection.•Carefully selected gastric cancer patients have good survival after local excision.•Local excision for inappropriate candidates has a high margin positivity rate.•Margin positivity is associated with poor survival in early gastric cancer.</description><identifier>ISSN: 0960-7404</identifier><identifier>EISSN: 1879-3320</identifier><identifier>DOI: 10.1016/j.suronc.2023.101937</identifier><identifier>PMID: 37058972</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenocarcinoma - pathology ; Digestive System Surgical Procedures ; Gastric cancer ; Humans ; Local excision ; Neoplasm Staging ; Outcomes ; Rectal Neoplasms - pathology ; Retrospective Studies ; Stomach Neoplasms - pathology ; Survival ; Treatment Outcome ; United States - epidemiology</subject><ispartof>Surgical oncology, 2023-06, Vol.48, p.101937-101937, Article 101937</ispartof><rights>2023</rights><rights>Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-69afc9582ba10ea1dd0b368c7888e799284f6c1500b6a5487e646f8f7e6c16a63</cites><orcidid>0000-0002-4324-9530 ; 0000-0002-3931-0861 ; 0000-0003-3057-8316</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37058972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Newland, John J.</creatorcontrib><creatorcontrib>Johnson, Abree M.</creatorcontrib><creatorcontrib>Feng, Zhaoyong</creatorcontrib><creatorcontrib>Kim, Raymond E.</creatorcontrib><creatorcontrib>Williams, Richelle T.</creatorcontrib><creatorcontrib>Hanna, Nader N.</creatorcontrib><creatorcontrib>Mullins, C. Daniel</creatorcontrib><creatorcontrib>Hu, Yinin</creatorcontrib><title>Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States</title><title>Surgical oncology</title><addtitle>Surg Oncol</addtitle><description>Local excision (LE) for early-stage gastric cancer has expanded in the United States over recent years, however, national outcomes are unknown. The objective of the study was to evaluate national survival outcomes following LE for early-stage gastric cancer. Patients with resectable gastric adenocarcinoma between 2010 and 2016 were identified from the National Cancer Database then classified by LE curability into eCuraA (high) and eCuraC (low) according to Japanese Gastric Cancer Association guidelines. Demographics, clinical/provider descriptors, and perioperative/survival outcomes were extracted. Propensity-weighted cox proportional hazards regression assessed factors associated with overall survival. Patients were stratified into eCuraA (N = 1167) and eCuraC (N = 13,905) subgroups. Postoperative 30-day mortality (0% vs 2.8%, p &lt; 0.001) and readmission (2.3% vs 7.8%, p = 0.005) favored LE. Local excision was not associated with survival on propensity-weighted analyses. However, among eCuraC patients, LE was associated with higher likelihood of positive margins (27.1% vs 7.0%, p &lt; 0.001), which was the strongest predictor of poor survival (HR 2.0, p &lt; 0.001). Although early morbidity is low, oncologic outcomes following LE are compromised for eCuraC patients. These findings support careful patient selection and treatment centralization in the early adoption phase of LE for gastric cancer. •Local excision has lower morbidity and mortality than radical resection.•Carefully selected gastric cancer patients have good survival after local excision.•Local excision for inappropriate candidates has a high margin positivity rate.•Margin positivity is associated with poor survival in early gastric cancer.</description><subject>Adenocarcinoma - pathology</subject><subject>Digestive System Surgical Procedures</subject><subject>Gastric cancer</subject><subject>Humans</subject><subject>Local excision</subject><subject>Neoplasm Staging</subject><subject>Outcomes</subject><subject>Rectal Neoplasms - pathology</subject><subject>Retrospective Studies</subject><subject>Stomach Neoplasms - pathology</subject><subject>Survival</subject><subject>Treatment Outcome</subject><subject>United States - epidemiology</subject><issn>0960-7404</issn><issn>1879-3320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAQhi0EotvCP0DIRy5Zxk7ijwsSqvioVKkH6NnyTibFq8RebAfRf09WKRw5jTR63nk1D2NvBOwFCPX-uC9LThH3EmR7XtlWP2M7YbRt2lbCc7YDq6DRHXQX7LKUIwAoLcVLdtFq6I3VcsfwbqmYZircj5UypzikgukUkE8J_cTpN4YSUuRp5OTz9NiU6h-IP_hS80r5geIKZgwxzZ6HyOsP4vcxVBr4t-orlVfsxeinQq-f5hW7__zp-_XX5vbuy831x9sGWyFqo6wf0fZGHrwA8mIY4NAqg9oYQ9paabpRoegBDsr3ndGkOjWacZ0olFftFXu33T3l9HOhUt0cCtI0-UhpKU6aVZIB28sV7TYUcyol0-hOOcw-PzoB7qzXHd2m1531uk3vGnv71LAcZhr-hf76XIEPG0Drn78CZVcwUEQaQiasbkjh_w1_AKxljmA</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Newland, John J.</creator><creator>Johnson, Abree M.</creator><creator>Feng, Zhaoyong</creator><creator>Kim, Raymond E.</creator><creator>Williams, Richelle T.</creator><creator>Hanna, Nader N.</creator><creator>Mullins, C. Daniel</creator><creator>Hu, Yinin</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4324-9530</orcidid><orcidid>https://orcid.org/0000-0002-3931-0861</orcidid><orcidid>https://orcid.org/0000-0003-3057-8316</orcidid></search><sort><creationdate>202306</creationdate><title>Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States</title><author>Newland, John J. ; Johnson, Abree M. ; Feng, Zhaoyong ; Kim, Raymond E. ; Williams, Richelle T. ; Hanna, Nader N. ; Mullins, C. Daniel ; Hu, Yinin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-69afc9582ba10ea1dd0b368c7888e799284f6c1500b6a5487e646f8f7e6c16a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Digestive System Surgical Procedures</topic><topic>Gastric cancer</topic><topic>Humans</topic><topic>Local excision</topic><topic>Neoplasm Staging</topic><topic>Outcomes</topic><topic>Rectal Neoplasms - pathology</topic><topic>Retrospective Studies</topic><topic>Stomach Neoplasms - pathology</topic><topic>Survival</topic><topic>Treatment Outcome</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Newland, John J.</creatorcontrib><creatorcontrib>Johnson, Abree M.</creatorcontrib><creatorcontrib>Feng, Zhaoyong</creatorcontrib><creatorcontrib>Kim, Raymond E.</creatorcontrib><creatorcontrib>Williams, Richelle T.</creatorcontrib><creatorcontrib>Hanna, Nader N.</creatorcontrib><creatorcontrib>Mullins, C. Daniel</creatorcontrib><creatorcontrib>Hu, Yinin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Newland, John J.</au><au>Johnson, Abree M.</au><au>Feng, Zhaoyong</au><au>Kim, Raymond E.</au><au>Williams, Richelle T.</au><au>Hanna, Nader N.</au><au>Mullins, C. Daniel</au><au>Hu, Yinin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States</atitle><jtitle>Surgical oncology</jtitle><addtitle>Surg Oncol</addtitle><date>2023-06</date><risdate>2023</risdate><volume>48</volume><spage>101937</spage><epage>101937</epage><pages>101937-101937</pages><artnum>101937</artnum><issn>0960-7404</issn><eissn>1879-3320</eissn><abstract>Local excision (LE) for early-stage gastric cancer has expanded in the United States over recent years, however, national outcomes are unknown. The objective of the study was to evaluate national survival outcomes following LE for early-stage gastric cancer. Patients with resectable gastric adenocarcinoma between 2010 and 2016 were identified from the National Cancer Database then classified by LE curability into eCuraA (high) and eCuraC (low) according to Japanese Gastric Cancer Association guidelines. Demographics, clinical/provider descriptors, and perioperative/survival outcomes were extracted. Propensity-weighted cox proportional hazards regression assessed factors associated with overall survival. Patients were stratified into eCuraA (N = 1167) and eCuraC (N = 13,905) subgroups. Postoperative 30-day mortality (0% vs 2.8%, p &lt; 0.001) and readmission (2.3% vs 7.8%, p = 0.005) favored LE. Local excision was not associated with survival on propensity-weighted analyses. However, among eCuraC patients, LE was associated with higher likelihood of positive margins (27.1% vs 7.0%, p &lt; 0.001), which was the strongest predictor of poor survival (HR 2.0, p &lt; 0.001). Although early morbidity is low, oncologic outcomes following LE are compromised for eCuraC patients. These findings support careful patient selection and treatment centralization in the early adoption phase of LE for gastric cancer. •Local excision has lower morbidity and mortality than radical resection.•Carefully selected gastric cancer patients have good survival after local excision.•Local excision for inappropriate candidates has a high margin positivity rate.•Margin positivity is associated with poor survival in early gastric cancer.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>37058972</pmid><doi>10.1016/j.suronc.2023.101937</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4324-9530</orcidid><orcidid>https://orcid.org/0000-0002-3931-0861</orcidid><orcidid>https://orcid.org/0000-0003-3057-8316</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-7404
ispartof Surgical oncology, 2023-06, Vol.48, p.101937-101937, Article 101937
issn 0960-7404
1879-3320
language eng
recordid cdi_proquest_miscellaneous_2801980952
source ScienceDirect Freedom Collection
subjects Adenocarcinoma - pathology
Digestive System Surgical Procedures
Gastric cancer
Humans
Local excision
Neoplasm Staging
Outcomes
Rectal Neoplasms - pathology
Retrospective Studies
Stomach Neoplasms - pathology
Survival
Treatment Outcome
United States - epidemiology
title Outcomes after endoscopic local excision of early-stage gastric adenocarcinoma in the United States
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A21%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20after%20endoscopic%20local%20excision%20of%20early-stage%20gastric%20adenocarcinoma%20in%20the%20United%20States&rft.jtitle=Surgical%20oncology&rft.au=Newland,%20John%20J.&rft.date=2023-06&rft.volume=48&rft.spage=101937&rft.epage=101937&rft.pages=101937-101937&rft.artnum=101937&rft.issn=0960-7404&rft.eissn=1879-3320&rft_id=info:doi/10.1016/j.suronc.2023.101937&rft_dat=%3Cproquest_cross%3E2801980952%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-69afc9582ba10ea1dd0b368c7888e799284f6c1500b6a5487e646f8f7e6c16a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2801980952&rft_id=info:pmid/37058972&rfr_iscdi=true